Global Trust Asset Management, LLC Eli Lilly & CO Transaction History

Global Trust Asset Management, LLC

$266 Million
Q3 2024

A detailed history of Global Trust Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 1,668 shares of LLY stock, worth $1.32 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

1,668

Previous 1,002 66.47%

Holding current value

$1.32 Million

Previous $907,000 62.84%

% of portfolio

0.56%

Previous 0.37%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$772.14 - $960.02 $514,245 - $639,373	666 Added 66.47%	1,668 $1.48 Million
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $177,660 - $237,684	-300 Reduced 23.04%	1,002 $779,000
Q1 2023 Apr 14, 2023	SELL	$310.63 - $364.82 $100,954 - $118,566	-325 Reduced 19.98%	1,302 $447,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $144,697 - $168,601	450 Added 38.23%	1,627 $595,000
Q3 2022 Oct 07, 2022	SELL	$296.48 - $337.87 $14,824 - $16,893	-50 Reduced 4.07%	1,177 $381,000
Q2 2022 Jul 12, 2022	BUY	$278.73 - $327.27 $146,333 - $171,816	525 Added 74.79%	1,227 $398,000
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $306,935 - $397,018	-1,700 Reduced 70.77%	702 $161,000
Q1 2021 Apr 14, 2021	BUY	$164.32 - $212.72 $279,344 - $361,624	1,700 Added 242.17%	2,402 $449,000
Q4 2020 Jan 13, 2021	SELL	$130.46 - $172.63 $6,653 - $8,804	-51 Reduced 6.77%	702 $119,000
Q3 2020 Nov 17, 2020	BUY	$146.22 - $169.13 $146 - $169	1 Added 0.13%	753 $109,000
Q2 2020 Jul 08, 2020	SELL	$136.42 - $164.18 $429,722 - $517,167	-3,150 Reduced 80.73%	752 $124,000
Q1 2020 Apr 06, 2020	BUY	$119.05 - $147.35 $380,960 - $471,520	3,200 Added 455.84%	3,902 $540,000
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $638,604 - $694,636	-5,980 Reduced 89.49%	702 $79,000
Q2 2019 Jul 23, 2019	BUY	$110.79 - $129.32 $662,524 - $773,333	5,980 Added 851.85%	6,682 $84,000
Q1 2019 Apr 05, 2019	SELL	$111.31 - $131.02 $6,567 - $7,730	-59 Reduced 7.75%	702 $91,000
Q3 2018 Oct 16, 2018	BUY	$85.86 - $107.31 $33,227 - $41,528	387 Added 103.48%	761 $82,000
Q4 2017 Feb 02, 2018	BUY	$81.94 - $87.89 $30,645 - $32,870	374	374 $32,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Trust Asset Management, LLC with notifications on news.

Account

Global Trust Asset Management, LLC Eli Lilly & CO Transaction History